Document is current
Any future updates will be listed below
-
Authors
Li, Danni
Lu, Jiahao
Zhang, Qiying
Zhou, Yuzhu
Li, Long
Zhu, Hua
Li, Tong
-
Funding
Funding for this research was provided by:
Guangxi Natural Science Foundation (2017GXNSFBA198021, 2017GXNSFBA198021, 2017GXNSFBA198021, 2017GXNSFBA198021, 2017GXNSFBA198021, 2017GXNSFBA198021, 2017GXNSFBA198021)
Guangxi Key Laboratory of Zhuang and Yao Ethnic Medicine ((2014) No.32, (2014) No.32, (2014) No.32, (2014) No.32, (2014) No.32, (2014) No.32, (2014) No.32)
Collaborative Innovation Center of Zhuang and Yao EthnicMedicine ((2013) No.20, (2013) No.20, (2013) No.20, (2013) No.20, (2013) No.20, (2013) No.20, (2013) No.20)
- License Information
-
More Information
Article History
Received: 3 May 2022
Accepted: 28 September 2022
First Online: 9 October 2022
Declarations
:
: Li-7 human hepatocellular carcinoma line did not require ethics approval for their use.
: Not applicable.
: The authors declare that they have no competing interests.
